glp 1 novo nordisk products Novo, Lilly buoyed by fast-growing GLP-1 drug sales Novo Nordisk sued Eli Lilly,

As GLP1s are becoming more commonly prescribed for obesity and other health conditions by providers across multiple disciplines, there is growing concern for the continued lack of formal medical training in nutrition and obesity and the paucity of basic knowledge and competencies to provide nutrition counseling [111, 112]

For more information contact: Ernie Ballard, Senior Director of Communications & Marketing, [email protected], 225-263-2677

Nature 630 (8017), 720727 (2024)

Importantly, if you have unexpectedly high B12 levels without taking supplements or receiving injections, this warrants GP review as it may indicate underlying liver disease, kidney disease, or certain blood disorders

Uchiyama, K

Nail Changes (Melanonychia) Brown-black discoloration of fingernails or toenails has been reported